We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+29.64%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$20B
AUM Growth
+$4.67B
Cap. Flow
+$1.41B
Cap. Flow %
7.05%
Top 10 Hldgs %
51.91%
Holding
145
New
23
Increased
33
Reduced
49
Closed
14

Top Sells

Rank Stock Value
1
NTES icon
NetEase
NTES
+$95.1M
2
XLNX
Xilinx Inc
XLNX
+$92.1M
3
BA icon
Boeing
BA
+$53.4M
4
SHW icon
Sherwin-Williams
SHW
+$52.2M
5
LVS icon
Las Vegas Sands
LVS
+$48.4M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Consumer Discretionary 5.64%
3 Communication Services 5.5%
4 Financials 4.18%
5 Industrials 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILI icon
101
Bilibili
BILI
$7.84B
$31.3M 0.16%
+1,650,000
New +$28.9M
RP
102
DELISTED
RealPage, Inc.
RP
$27.4M 0.14%
451,149
LKFT
103
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$20.6M 0.1%
+175,000
New +$17.6M
APO icon
104
Apollo Global Management
APO
$73.4B
$15.8M 0.08%
559,196
-1,057,804
-65% -$30.1M
DCPH
105
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$15.2M 0.08%
653,547
+155,000
+31% +$4.06M
JOYY
106
JOYY Inc
JOYY
$3.75B
$12.6M 0.06%
150,000
-474,153
-76% -$34.5M
KKR icon
107
KKR & Co
KKR
$92.3B
$11.7M 0.06%
500,000
-1,229,747
-71% -$28M
BPMC
108
DELISTED
Blueprint Medicines
BPMC
$10M 0.05%
125,000
-99,346
-44% -$7.34M
CLVT icon
109
Clarivate
CLVT
$1.16B
$9.74M 0.05%
+725,000
New +$8.05M
TCDA
110
DELISTED
Tricida, Inc. Common Stock
TCDA
$6.93M 0.03%
+179,400
New +$4.18M
VIPS icon
111
CALL
Vipshop
VIPS
$7.53B
$5.62M 0.03%
700,000
-200,000
-22% -$1.42M
NOW icon
112
ServiceNow
NOW
$129B
$4.93M 0.02%
+100,000
New +$4.4M
AYX
113
DELISTED
Alteryx Inc
AYX
$4.19M 0.02%
50,000
PCTY icon
114
Paylocity
PCTY
$7.98B
$2.68M 0.01%
+30,000
New +$2.33M
ZBRA icon
115
Zebra Technologies
ZBRA
$17.8B
$2.62M 0.01%
+12,500
New +$2.35M
CYBR
116
DELISTED
CyberArk
CYBR
$2.2M 0.01%
+18,500
New +$1.77M
STML
117
DELISTED
Stemline Therapeutics, Inc.
STML
$1.99M 0.01%
155,000
+85,000
+121% +$961K
QTWO icon
118
Q2 Holdings
QTWO
$3.92B
$1.73M 0.01%
+25,000
New +$1.56M
IBB icon
119
iShares Biotechnology ETF
IBB
$9.77B
$1.68M 0.01%
15,000
PYPL icon
120
PayPal
PYPL
$50.5B
$1.38M 0.01%
13,281
PTC icon
121
PTC
PTC
$16B
$1.29M 0.01%
+14,000
New +$1.24M
AXSM icon
122
Axsome Therapeutics
AXSM
$10.9B
$1.14M 0.01%
+80,000
New +$743K
ALTR
123
DELISTED
Altair Engineering Inc
ALTR
$1.1M 0.01%
+30,000
New +$1.01M
COST icon
124
Costco
COST
$420B
$659K ﹤0.01%
2,722
ARQL
125
DELISTED
Arqule Inc
ARQL
$479K ﹤0.01%
+100,000
New +$386K

Similar funds

Alkeon Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Alkeon Capital Management held 145 positions worth $20B, up 30% from $15.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Alkeon Capital Management deployed $1.41B of net new capital in Q1 2019, opening 23 new positions and adding to 33 existing holdings. Its largest new stake was TransDigm Group: 237,219 shares worth $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was NetEase, an estimated $95.1M trimmed.

  • Alkeon Capital Management's largest Q1 2019 buy was TransDigm Group: 237,219 shares worth $108M.
  • Alkeon Capital Management added most to ASPEN TECHNOLOGY INC in Q1 2019, an estimated $61M increase.
  • Alkeon Capital Management's biggest Q1 2019 reduction was NetEase, cutting an estimated $95.1M.
  • Alkeon Capital Management fully exited Broadcom in Q1 2019, selling an estimated $43.5M.
  • Alkeon Capital Management's ten largest holdings make up 52% of its $20B portfolio in Q1 2019.
  • Alkeon Capital Management opened 23 new positions and closed 14 in Q1 2019.
  • Alkeon Capital Management's portfolio value rose 30% quarter-over-quarter to $20B.

Based on Alkeon Capital Management's 13F filing for Q1 2019, filed 15 May 2019.